Loading
MO
Mural Oncology plc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 15 Aug 2024.
Mural Oncology plc: what insiders have been doing
Mural Oncology plc is a listed company. Filings by its managers are published through SEC (Form 4). The last twelve months, up to 18 October 2026, brought 6 filings signed by 4 insiders.
There is no open-market purchase to report; the filings show 2 sales worth €22k by 2 insiders. The largest single trade was a sale of €13k by Cutler Adam D., published on 10 November 2025.
Compared with its exchange (5,808 companies, median 19 filings), a count of 6 filings is below the norm. The full history, which starts in 2023, counts 1 purchase against 12 sales.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
27
Thresholds
n/a
Buy Volume
€29,120
1 ops. · all time
Sell Volume
€203,394
12 ops. · all time
Who traded when
BuySaleMaiken Keson-Brookes3 sales
Vicki L. Goodman3 sales
Caroline Loew2 sales
Adam D. Cutler1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
Income statement
Net income-US$111.3M
Last declaration on 5 December 2025
Declarations27 total
293,059 sharesOrdinary SharesSEC:0001193125-25-308787:0
68,834 sharesOrdinary SharesSEC:0001193125-25-308760:0
84,727 sharesOrdinary SharesSEC:0001193125-25-308745:0
99,290 sharesOrdinary SharesSEC:0001193125-25-308739:0
7,148 shares@ US$2.0935.7% of flowOrdinary SharesSEC:0001193125-25-274768:0
5,036 shares@ US$2.0812.3% of flowOrdinary SharesSEC:0001193125-25-274765:0
2,572 shares@ US$2.4821.9% of flowOrdinary SharesSEC:0000950170-25-097949:0
2,158 shares@ US$2.4818.6% of flowOrdinary SharesSEC:0000950170-25-097599:0
12,531 shares@ US$2.43237.9% of flowOrdinary SharesSEC:0000950170-25-094831:0
35,000 shares0Ordinary SharesSEC:0000950170-25-033769:0
72,275 shares0Ordinary SharesSEC:0000950170-25-033766:0
35,000 shares0Ordinary SharesSEC:0000950170-25-033764:0
35,000 shares0Ordinary SharesSEC:0000950170-25-033761:0
13,186 shares@ US$3.8966.4% of flowOrdinary SharesSEC:0000950170-25-026609:0
2,555 shares@ US$3.2732.3% of flowOrdinary SharesSEC:0000950170-24-140393:0
2,763 shares@ US$3.4013.0% of flowOrdinary SharesSEC:0000950170-24-137877:0
5,069 shares@ US$3.3321.3% of flowOrdinary SharesSEC:0000950170-24-124041:0
7,421 shares@ US$3.4164.3% of flowOrdinary SharesSEC:0000950170-24-119800:0
10,000 shares@ US$3.2071100.0% of flowOrdinary SharesSEC:0000950170-24-097576:0
Canonical exit: 12 Nov 2024 (T+90)
2,157 shares@ US$3.4127.2% of flowOrdinary SharesSEC:0000950170-24-084569:0
12,531 shares@ US$2.9149.1% of flowOrdinary SharesSEC:0000950170-24-082244:0
16,800 shares0Ordinary SharesSEC:0000950170-24-024913:0
48,475 shares0Ordinary SharesSEC:0000950170-24-024968:0
29,207 shares0Ordinary SharesSEC:0000950170-23-071106:0
73,018 shares0Ordinary SharesSEC:0000950170-23-071113:0
25 of 27 declarations
About Mural Oncology plc
Mural Oncology plc is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on NASDAQ under the ticker MURAL.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
